Glipizide
Product Images NDC 66336-269

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 66336-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0269-xx (Ndc 66336 0269 Xx Patheon)

This is a medication with the active component Glipizide ER 10 mg. The product comes in a white, coated, round tablet with WPI 845 printed in black, packed in a light-resistant container. The medication should be taken orally once a day with breakfast, swallowed whole, and not chewed, crushed, or divided. The medication may cause drowsiness or dizziness, and alcohol should be avoided. Each tablet is extended-release, and the medication should be kept in a controlled temperature environment between 68-77°F. The medication should be kept away from children. The manufacturer is Patheon Pharmaceuticals INC. located in Cincinnati, OH 45237.*

FDA Label Image

Structural Formula For Glipizide (Glipizide Extended Release Tablet 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.